Literature DB >> 23385398

Quantitative and semiquantitative measures of regional pulmonary microvascular perfusion by magnetic resonance imaging and their relationships to global lung perfusion and lung diffusing capacity: the multiethnic study of atherosclerosis chronic obstructive pulmonary disease study.

Katja Hueper1, Megha A Parikh, Martin R Prince, Christian Schoenfeld, Chia Liu, David A Bluemke, Stephen M Dashnaw, Thomas A Goldstein, Eric A Hoffman, Joao A Lima, Jan Skrok, Jie Zheng, R Graham Barr, Jens Vogel-Claussen.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the quantitative and semiquantitative measures of regional pulmonary parenchymal perfusion in patients with chronic obstructive pulmonary disease (COPD) in relationship to global lung perfusion (GLP) and lung diffusing capacity (DLCO).
MATERIALS AND METHODS: A total of 143 participants in the Multiethnic Study of Atherosclerosis COPD Study were examined by dynamic contrast-enhanced pulmonary perfusion magnetic resonance imaging (MRI) at 1.5 T. Pulmonary microvascular blood flow (PBF) was calculated on a pixel-by-pixel basis by using a dual-bolus technique and the Fermi function model. Semiquantitative parameters for regional pulmonary microvascular perfusion were calculated from signal intensity-time curves in the lung parenchyma. Intraoberserver and interobserver coefficients of variation (CVs) and correlations between quantitative and semiquantitative MRI parameters and with GLP and DLCO were determined.
RESULTS: Quantitative and semiquantitative parameters of pulmonary microvascular perfusion were reproducible, with CVs for all parameters of less than 10%. Furthermore, these MRI parameters were correlated with GLP and DLCO, and there was good agreement between PBF and GLP. Quantitative and semiquantitative MRI parameters were closely correlated (eg, r = 0.86 for maximum signal increase with PBF). In participants without COPD, the physiological distribution of pulmonary perfusion could be determined by regional MRI measurements.
CONCLUSION: Regional pulmonary microvascular perfusion can reliably be quantified from dynamic contrast-enhanced MRI. Magnetic resonance imaging-derived quantitative and semiquantitative perfusion measures correlate with GLP and DLCO.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23385398      PMCID: PMC3952075          DOI: 10.1097/RLI.0b013e318281057d

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  32 in total

1.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

2.  Quantification of pulmonary blood flow and volume in healthy volunteers by dynamic contrast-enhanced magnetic resonance imaging using a parallel imaging technique.

Authors:  Konstantin Nikolaou; Stefan O Schoenberg; Gunnar Brix; Jeffrey P Goldman; Ulrike Attenberger; Bernd Kuehn; Olaf Dietrich; Maximilian F Reiser
Journal:  Invest Radiol       Date:  2004-09       Impact factor: 6.016

3.  Quantitative evaluation of MR perfusion imaging using blood pool contrast agent in subjects without pulmonary diseases and in patients with pulmonary embolism.

Authors:  Andreas Hansch; Peter Kohlmann; Uta Hinneburg; Joachim Boettcher; Ansgar Malich; Gunter Wolf; Hendrik Laue; Alexander Pfeil
Journal:  Eur Radiol       Date:  2012-04-01       Impact factor: 5.315

4.  Quantitative measurement of regional pulmonary blood flow with positron emission tomography.

Authors:  M A Mintun; M M Ter-Pogossian; M A Green; L L Lich; D P Schuster
Journal:  J Appl Physiol (1985)       Date:  1986-01

5.  Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time?

Authors:  R M Weisskoff; D Chesler; J L Boxerman; B R Rosen
Journal:  Magn Reson Med       Date:  1993-04       Impact factor: 4.668

6.  Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD.

Authors:  S Santos; V I Peinado; J Ramírez; T Melgosa; J Roca; R Rodriguez-Roisin; J A Barberà
Journal:  Eur Respir J       Date:  2002-04       Impact factor: 16.671

7.  Quantitative assessment of regional pulmonary perfusion in the entire lung using three-dimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: Preliminary experience in 40 subjects.

Authors:  Yoshiharu Ohno; Hiroto Hatabu; Kenya Murase; Takanori Higashino; Hideaki Kawamitsu; Hirokazu Watanabe; Daisuke Takenaka; Masahiko Fujii; Kazuro Sugimura
Journal:  J Magn Reson Imaging       Date:  2004-09       Impact factor: 4.813

8.  Lung volumes in healthy nonsmoking adults.

Authors:  R O Crapo; A H Morris; P D Clayton; C R Nixon
Journal:  Bull Eur Physiopathol Respir       Date:  1982 May-Jun

9.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

10.  Measurement of regional pulmonary blood flow with PET.

Authors:  D P Schuster; J D Kaplan; K Gauvain; M J Welch; J Markham
Journal:  J Nucl Med       Date:  1995-03       Impact factor: 10.057

View more
  20 in total

1.  Pulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary Disease and Emphysema. The MESA COPD Study.

Authors:  Katja Hueper; Jens Vogel-Claussen; Megha A Parikh; John H M Austin; David A Bluemke; James Carr; Jiwoong Choi; Thomas A Goldstein; Antoinette S Gomes; Eric A Hoffman; Steven M Kawut; Joao Lima; Erin D Michos; Wendy S Post; Ming Jack Po; Martin R Prince; Kiang Liu; Dan Rabinowitz; Jan Skrok; Ben M Smith; Karol Watson; Youbing Yin; Alan M Zambeli-Ljepovic; R Graham Barr
Journal:  Am J Respir Crit Care Med       Date:  2015-09-01       Impact factor: 21.405

2.  Developing and Implementing Biomarkers and Novel Imaging in COPD.

Authors:  Surya P Bhatt; Meilan K Han
Journal:  Chronic Obstr Pulm Dis       Date:  2016-01-15

3.  Cor pulmonale parvus in chronic obstructive pulmonary disease and emphysema: the MESA COPD study.

Authors:  Steven M Kawut; Hooman D Poor; Megha A Parikh; Katja Hueper; Benjamin M Smith; David A Bluemke; João A C Lima; Martin R Prince; Eric A Hoffman; John H M Austin; Jens Vogel-Claussen; R Graham Barr
Journal:  J Am Coll Cardiol       Date:  2014-11-03       Impact factor: 24.094

4.  Comparison of models and contrast agents for improved signal and signal linearity in dynamic contrast-enhanced pulmonary magnetic resonance imaging.

Authors:  Laura C Bell; Kang Wang; Alejandro Munoz Del Rio; Thomas M Grist; Sean B Fain; Scott K Nagle
Journal:  Invest Radiol       Date:  2015-03       Impact factor: 6.016

5.  Acute and Chronic Cardiopulmonary Effects of High Dose Interleukin-2 Therapy: An Observational Magnetic Resonance Imaging Study.

Authors:  Jakub Lagan; Josephine H Naish; Christien Fortune; Christopher Campbell; Shien Chow; Manon Pillai; Joshua Bradley; Lenin Francis; David Clark; Anita Macnab; Gaetano Nucifora; Rebecca Dobson; Erik B Schelbert; Matthias Schmitt; Robert Hawkins; Christopher A Miller
Journal:  Diagnostics (Basel)       Date:  2022-05-30

6.  High temporal versus high spatial resolution in MR quantitative pulmonary perfusion imaging of two-year old children after congenital diaphragmatic hernia repair.

Authors:  M Weidner; F G Zöllner; C Hagelstein; K Zahn; T Schaible; S O Schoenberg; L R Schad; K W Neff
Journal:  Eur Radiol       Date:  2014-07-20       Impact factor: 5.315

7.  Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease study.

Authors:  Michael A Thomashow; Daichi Shimbo; Megha A Parikh; Eric A Hoffman; Jens Vogel-Claussen; Katja Hueper; Jessie Fu; Chia-Ying Liu; David A Bluemke; Corey E Ventetuolo; Margaret F Doyle; R Graham Barr
Journal:  Am J Respir Crit Care Med       Date:  2013-07-01       Impact factor: 21.405

8.  Particulate Matter Exposure and Cardiopulmonary Differences in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Carrie P Aaron; Yana Chervona; Steven M Kawut; Ana V Diez Roux; Mingwu Shen; David A Bluemke; Victor C Van Hee; Joel D Kaufman; R Graham Barr
Journal:  Environ Health Perspect       Date:  2016-02-09       Impact factor: 9.031

9.  Morpho-Functional 1H-MRI of the Lung in COPD: Short-Term Test-Retest Reliability.

Authors:  Bertram J Jobst; Mark O Wielpütz; Simon M F Triphan; Angela Anjorin; Julia Ley-Zaporozhan; Hans-Ulrich Kauczor; Jürgen Biederer; Sebastian Ley; Oliver Sedlaczek
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

Review 10.  Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD.

Authors:  J Michael Wells; Mark T Dransfield
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.